Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banaras Beads Ltd
NSE:BANARBEADS
|
IN |
|
I
|
Irm Energy Ltd
NSE:IRMENERGY
|
IN |
Alliance Pharma PLC
Cash from Operating Activities
Alliance Pharma PLC
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash from Operating Activities
£38.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Operating Activities
£7.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Operating Activities
$14.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
25%
|
CAGR 10-Years
16%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Operating Activities
$436m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Cash from Operating Activities
-£28.1m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Animalcare Group PLC
LSE:ANCR
|
Cash from Operating Activities
£11.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
Alliance Pharma PLC
Glance View
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).
See Also
What is Alliance Pharma PLC's Cash from Operating Activities?
Cash from Operating Activities
38.7m
GBP
Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Cash from Operating Activities amounts to 38.7m GBP.
What is Alliance Pharma PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
Over the last year, the Cash from Operating Activities growth was 23%.
